Jerini raises EUR 31 million

Cancer, autoimmune and inflammation company Jerini (Berlin, Germany) raised EUR 31 million ($38.1 million) in a series B round co-led by HealthCap; TVM Techno Venture Management; and 3i. Other investors included Sanders Morris Harris; PolyTechnos Funds; IBB-Beteiligungsgesellschaft; and bmp. ...